Statins ‘not likely to cause much muscle pain’: Study New research has challenged the widespread view of statins’ link with muscle pain, leading to calls for medication labels to be revised.
CVD and diabetes rates spike post-COVID: Study The risk of contracting diabetes is especially high in the first four weeks after infection, but returns to baseline within months.
Unpacking diabetes and the heart SPONSORED: New medicines and emerging strategies to profile risk offer more options than ever to manage CVD risk in people with diabetes.
Most eligible patients ‘have not had recent heart checks’ The reported results of a Heart Foundation survey suggest many at-risk patients have not been screened within the past two years.
Australia needs a modern approach to assessing heart attack risk CT scanning of the heart has changed the way coronary artery disease risk can be assessed, writes cardiologist Professor Girish Dwivedi.
Preventable risk factors in childhood linked with midlife CVD Five childhood risk factors, individually or combined, have been identified as predictors of fatal and non-fatal cardiovascular events in adulthood.
Have the benefits of statins been overstated? Researcher Paula Byrne writes on what she and her colleagues learned from a meta-analysis of 21 clinical trials involving 140,000 patients.
Study finds statin intolerance overestimated and overdiagnosed Fewer than 10% of patients prescribed cholesterol-lowering drugs experience side effects, according to the world’s largest study on statin intolerance.
What GPs need to know about GLP-1 RAs SPONSORED: The medication has been described as a ‘paradigm shift’ in the way type 2 diabetes is managed.
How nutrition could make a significant difference to chronic disease A new study has highlighted the clear benefits of personalised nutrition support in community-based health services, such as general practice.